Dr Reddy's Pioneers Generic Semaglutide Launch in Canada
Published on: May 16, 2026, 11:44 a.m. | Source: Devdiscourse
Dr Reddy's Laboratories has introduced its generic Semaglutide injection for type 2 diabetes treatment in Canada. The launch makes Canada the first G7 country authorizing this generic, following Health Canada's approval. Dr Reddy's aims to enhance patient access to affordable GLP-1 therapies globally.
